Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.

Por Shenying Fang, Ralf Krahe, Guillermina Lozano, Younghun Han, Wei Chen, Sean M Post, Baili Zhang, Charmaine D Wilson, Linda L Bachinski, Louise C Strong, Christopher I Amos
Publicado em 2010-05-01